Introduction Claudins, membrane-associated tetraspanin proteins, are normally associated with the tight junctions of epithelial cells where they confer a variety of permeability properties to the transepithelial barrier. One member of this family, claudin 7, has been shown to be expressed in the human mammary epithelium and some breast tumors. To set the stage for functional experiments on this molecule, we examined the developmental expression and localization of claudin 7 in the murine mammary epithelium and in a selection of murine mammary tumors.
Introduction
The claudins comprise a large family of tetraspanin membrane proteins thought to be the major barrier-forming proteins of tight junctions, the cell-cell contacts at the apical border of epithelial cells that control the paracellular movement of solutes. These proteins are highly conserved, with four transmembrane domains and two hydrophobic extracellular loops; the latter are thought to mediate cell-cell adhesion [1] and to confer specific paracellular permeability properties on cell monolayers [2, 3] . Claudin 7 shares the general structural characteristics of the family, differing primarily in its amino-terminal cytoplasmic tail [4] . The molecule has been shown to be associated with epithelial cells in the human breast [5] , and its loss is associated with some breast and head and neck malignancies [5, 6] . It has been shown to be expressed in parts of the renal tubule [7] and the airway epithelium [8] , where it is localized to the basolateral aspects of the cells. Here we show that claudin 7 is constitutively present in the epithelium of the murine mammary gland, again localized, not to tight junctions but IHC = immunohistochemistry; PBS = phosphate-buffered saline.
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to punctate structures at or near the basolateral surfaces of the cells. It was present at all cell borders of several murine mammary tumors. Nonetheless, the protein can localize to tight junctions, as shown by its partial colocalization with ZO1 in cultured mammary epithelial cells and epididymis, suggesting a possible dual function depending on tissue type.
Method Animals and tissue preparation
CD-1 mice, purchased from Charles River Breeding Laboratory (Wilmington, DE), were maintained in the USDAapproved Animal Resource Center of the University of Colorado Health Sciences Center. All procedures were approved by the Institutional Animal Care and Use Committee. The fourth mammary glands of virgin female mice at 3, 6, and 12 weeks of age, of female mice during early gestation (5-7 days), mid-gestation (12 days) and late gestation (18 days), at days 2 and 10 of lactation, and at days 21 and 29 of involution were collected after killing with a lethal dose of pentobarbital. Liver, lung, and kidneys were obtained from virgin female mice and epididymis from male mice. The day on which vaginal plugs were observed was counted as day one of pregnancy. Mice overexpressing the Her2/neu oncogene [9] were obtained from Jackson Laboratories, and mammary tumors were dissected and frozen when they reached about 0.5 cm in diameter. The transplantation tumor models TM4, TM10L, and TM40 are maintained in the Medina laboratory as described [10] . Tissues were flash-frozen in liquid nitrogen in Tri-Zol reagent (Gibco BRL, Life Technologies) for total RNA purification. For protein extractions, the tissue was washed twice in 1 ml of phosphate-buffered saline (PBS) and then placed in 3 volumes of 1% Nonidet P40 buffer (25 mM Hepes-NaOH, pH 7.4; 150 mM NaCl, 4 mM EDTA, 1% Nonidet P40) containing protease inhibitors (10 µg/µl leupeptin, 10 µg/µl aprotinin, 10 µM pepstatin A, 1 mM phenylmethylsulphonyl fluoride, in dimethyl sulphoxide). For hybridizations and immunohistochemistry of frozen tissue in situ, tissues were placed in Tissue-Tek OCT 4583 Compound (Sakura, Torrance, CA) and flash-frozen in isopentane and liquid nitrogen. All samples were stored at -70°C until ready for use.
Characterization of an antibody against claudin 7
A rabbit antibody was custom-made against the carboxyterminal peptide of murine claudin 7, APRSYPKSNSS-KEYV, by Zymed Laboratories (San Francisco, CA). This affinity-purified antibody bound only a 23 kDa peptide by western blotting, did not cross-react with claudin 1, its closest congener, in claudin-1-transfected Cos cells or at the apical border of the mammary epithelium where claudin 1 is present at junctional complexes, and stained only epithelia where its mRNA has been demonstrated. Staining was blocked by preincubation of the antibody with the peptide. Cos cells transfected with full-length claudin 7 were stained by this antibody but not by an antibody against claudin 1.
Protocol for real-time polymerase chain reaction
For real-time reverse transcriptase polymerase chain reaction, RNA was purified with the Qiagen system: 1 µg of DNase-treated RNA was used for each reaction. Triplicate tissue samples were assayed in duplicate with the ABI Prism 7700 sequence detection system, with lung as the positive control. Primer sequences were as follows: murine claudin 7, forward 5' -CGAAGAAGGCCCGAATAGCT-3' (338-337), reverse 5' -GCTACCAAGGCAGCAAGACC-3' (407-388), probe5' -GCCACAATGAAAACAAT-GCCTCCAGTCA-3' (359-386); murine cytokeratin 19, forward 5' -TTTAAGACCATCGAGGAC-3', reverse 5' -TCATACTGACTTCTCATCTCAC-3'.
Immunohistochemistry and digital confocal microscopy
Rat anti-mouse ZO1 antibody was obtained from Chemicon International Inc. (Temecula, CA). Tissue sections were cut at 10 µm thickness from frozen blocks with a Damon/ IEC division minotome set at -18 to -20°C. Sections were collected onto Cell-Tak coated coverslips and were further vapor-fixed with paraformaldehyde for 15 min. Sections were never allowed to dry. PBS was added carefully so as to not disrupt the sections. Tissue was permeabilized with 1% Triton X-100 for 15 min, rinsed well with PBS and blocked with sterifiltered 10% normal donkey serum for 20 min. All antibody solutions were microfuged for 20 min before use. The claudin antibody was diluted 1:1000. Primary incubations were for 1 hour at 21-22°C, followed by extensive washes in PBS, generally six times for 5 min each. Secondary antibodies were diluted in accordance with the manufacturer's instructions, in PBS alone. The host species of all secondary antibodies was donkey and all secondary antibodies were cross-adsorbed against mouse serum proteins. Antibodies used were conjugated to fluorescein, CY3 or CY5. Secondary antibodies were combined with 0.6 µg/ml 4,6-diamidino-2-phenylindole, and incubated on the tissue for 1 hour. Coverslips were rinsed briefly and permitted to soak overnight in PBS.
Images were collected with SlideBook software (Intelligent Imaging Innovations, Inc., Denver, CO) on a Nikon Diaphot TMD microscope equipped for fluorescence with a xenon lamp and filter wheels (Sutter Instruments, Novato, CA), fluorescent filters (Chroma, Brattleboro, VT), cooled chargecoupled device camera (Cooke, Tonawanda, NY) and stepper motor (Intelligent Imaging Innovations, Inc., Denver, CO). Multi-fluor images were merged, deconvolved, and renormalized with SlideBook software.
Results
Developmental expression of claudin 7 mRNA in the mammary gland Figure 1a shows claudin 7 gene expression as a function of developmental stage in the mouse mammary gland from the virgin animal (non-pregnant non-lactating) through pregnancy (days P5, P12, and P18), lactation (days L2, L10, and L19), and involution (days L22 and L29). Gene expression increased more than 1000-fold between the virgin and early lactating gland, leveling out through lactation and decreasing at late involution (day L29) with the loss of epithelial cells. To determine whether expression of claudin 7 was a function of developmental stage or epithelial cell number, we also examined the expression of keratin 19, found only in luminal epithelial cells [11] . As can be seen, claudin 7 expression parallels that of keratin 19. Further, the ratio of claudin 7 to keratin 19 ( Fig. 1a , dotted line) is relatively constant through pregnancy and early lactation, increasing only during later lactation when the expression of keratin 19 mRNA decreases significantly.
At late involution, day L29, claudin 7 expression was lower than that of keratin 19, for reasons that are not clear but probably have to do with the types and characteristics of epithelial cells present during late glandular remodeling. Similar results were obtained from microarray analysis (data not shown). In situ hybridization with 35 S-labeled RNA probes to claudin 7 showed that the mRNA was localized to the epithelium in virgin, pregnant, and lactating animals (Fig. 1b) . We conclude that, in the normal mammary gland, claudin 7 is an epithelial cell marker expressed at approximately constant levels through development. The very large changes in expression levels during pregnancy most probably reflect an increase in cell number as the mammary epithelium expands from a system of sparse ducts in the virgin gland, to a dense mass of lactating cells in a gland in which the adipose tissue is largely obliterated.
Immunolocalization of claudin 7 in the mammary gland
We made and characterized an affinity-purified antibody against the cytoplasmic tail of claudin 7 (see Methods) that proved quite satisfactory for both western blots (Fig. 2a) and immunohistochemistry on both frozen and paraffin sections. Given the well-known association of claudins with tight junctions, we were surprised to find that claudin stained the basolateral region of mammary cells in all stages of development (Fig. 2b,c) . A ductal structure surrounded by adipose stroma is shown in the virgin; alveoli from the pregnant and lactating glands are also shown (Fig.  2b) . Staining was blocked when the antibody was preabsorbed with the claudin 7 peptide against which it was made (Fig. 2b, lower right) . As with the in situ analysis, stain was observed only in luminal epithelial cells. Although there seems to be some colocalization of claudin 7 with stain for the tight-junction scaffolding protein ZO1 in the lowerpower images of Fig. 2b , at higher magnification (Fig. 2c) claudin 7 was entirely localized to the basal and lateral cytoplasmic regions, where it often appeared punctate in nature, particularly when it was not closely apposed to the cell border. Stain was excluded from nuclei (blue) and largely from tight junctions (green), as shown by the minimal overlap between the green and red stain in Fig. 2c . It seems likely that there is basolateral membrane staining in this tissue, but the basal and lateral membranes of the mammary epithelial cells are deeply infolded and membrane localization cannot be assessed at the magnifications possible with the light microscope.
When immunohistochemistry is used in the characterization of claudins, there is always a concern that the antibody cross-reacts with another claudin species. We have found claudins 1, 3, and 8 in the murine mammary epithelium (MC Neville, unpublished data); however, claudin 7 stain shows entirely different patterns from these claudins. As shown in Fig. 2a, claudin 1 is localized at the position of the junctional complexes; claudin 3 is present in epithelium from virgin and pregnant glands, whereas claudin 8 is present only during lactation. These experiments will be described in detail elsewhere.
Claudin 7 localization in other cell types
Sukumar and colleagues [5] reported that claudin 7 was localized to tight junctions of the human mammary carcinoma cell line MCF-7 by using an antibody directed toward the cytoplasmic tail of the human protein, which differs by one amino acid from the mouse protein. We therefore examined claudin 7 staining in the normal mouse mammary cell line EPH4 [12, 13] . Figure 3a shows the distribution of claudin and ZO-1 in EPH4 cells. Claudin 7 distinctly colocalizes with ZO-1 with a slightly less compact distribution, as shown by the zy image at the top of the figure as well as the xy image just below. A scattering of cytoplasmic vesicles containing claudin 7 can also be seen. This finding suggests that claudin 7 is capable of localizing to tight junctions, a conclusion supported by the distribution of claudin 7 in the epididymis (Fig. 3b) , where claudin 7 colocalized with ZO-1 at the apical borders of some cells but not others. Punctate cytoplasmic stain for claudin 7 could also be observed in some cells.
Claudin 7 mRNA was reported in lung and kidney, with liver being negative [4] . We therefore examined these tissues and found that claudin 7 was present in cells lining bronchiolar structures of the lung, where its distribution was mainly cytoplasmic as observed previously [8] (Fig. 3c) . However, careful examination of a black-and-white image at the highest magnification in the luminal cells of this structure shows some claudin 7 to be colocalized with ZO-1, suggesting that it might also be associated with tight junctions in these cells. There was no stain in the pulmonary alveoli. In the renal cortex we found claudin 7 localized only to certain segments, identified as connecting tubules and cortical collecting ducts by Li and colleagues [7] , where stain was distinctly basolateral (Fig. 3d ). Because our antibody was different from that used by Li and colleagues, our finding [7] . Claudin 7 shows a punctate distribution that is heaviest in the basal portion of the cells. (e) Liver. Tight junctions at the bile canaliculi are stained with ZO-1. However, no stain for claudin 7 is apparent. The magnification for each figure is indicated by the label (u, µm) above the scale bar. confirms this localization. At high magnification the stain is punctate, as in the mammary and airway epithelia. No specific claudin stain was observed in the liver (Fig. 3e) . These findings indicate that claudin 7 is capable of localizing to tight junctions, as in cultured mammary epithelial cells and epididymis; however, in mammary gland, airway, and kidney it is mostly or entirely confined to punctate cytoplasmic structures, often near the basolateral surfaces of the cells and possibly associated with the basolateral membranes. In no tissue was the protein observed in nuclei.
Claudin 7 localization in mammary tumors
We examined four types of mammary tumor: tumors arising in the transgenic mouse expressing the Erb2 receptor under the control of the mammary tumor virus promoter [9] , and three transplantable tumors obtained from the laboratory of DM [10] . All tumors expressed claudin 7 mRNA at levels no more than twice that in the lactating mammary gland when normalized to ribosomal RNA (Fig. 4a) . Although tumors themselves are more closely related to the pregnant gland, we chose the lactating gland for comparison because, like the tumors, it is composed largely of epithelial cells. Interestingly, the ratio of claudin 7 to keratin 19 in the tumors ranged from 4 to 60 times that in the lactating gland, reflecting a lower expression of keratin 19, and possibly a loss of differentiation, in the tumors. In all murine tumors examined here, claudin 7 was localized to the perimembrane region, as illustrated by a section of the TM4 tumor (Fig. 4b) . None of these tumors showed ZO1 staining, indicating that they lacked tight junctions, so that the claudin 7 observed here was probably associated with membrane vesicles and possibly with basolateral membranes, as in the normal cells of the mammary gland. Sukumar and colleagues [5] observed a loss of claudin 7 expression in some human tumors, particularly lobular tumors. However, this finding was not true of the mouse mammary tumors examined.
Discussion
We find claudin 7 to be a constitutive component of the mammary epithelium, where it is localized to the basolateral regions of the cell. The finding that the ratio of its mRNA to that of keratin 19 is relatively constant throughout the developmental cycle suggests that the molecule might be an alternative marker to keratin for the proportion of epithelial cells in the mammary gland. It is not clear whether the more than 1000-fold increase in expression between the virgin gland and early lactation indicates that the number of epithelial cells increases in this proportion, because part of the increase could be a function of an increase in cell size as the cells differentiate. The rapid increase between the virgin gland and pregnancy day 5 is consistent with studies showing a peak of thymidine incorporation between days 2 and 5 of pregnancy, when about 25% of the cells were labeled [14, 15] . In both studies, labeling decreased thereafter but remained about 10% almost to the end of pregnancy, consistent with the continued increase in both claudin 7 and keratin mRNA up to day P18.
Our findings are consistent with images of claudin staining in the human mammary gland, where a diffuse diaminobenzidene stain from alkaline phosphatase localization was present throughout the cytoplasm [5] . However, in that study no attempt was made to localize claudin 7 stain with tight-junction components. Basolateral localization of other claudins has been observed. Claudin 1 was localized to the cytoplasm in the epididymis [16] , intestine [17] , and cornea [18] . Rahner and colleagues [19] observed claudins 3, 4, and 5 to be laterally distributed in various portions of the gastrointestinal track. The finding that claudin 7 is exclusively located in non-tight-junction regions of mammary and renal epithelial cells [7] suggests that claudins might have functions other than the regulation of tight-junction permeability. Our images seem to be the first to show claudin 7 stain at sufficiently high resolution to show punctate cytoplasmic stain in mammary, airway, and renal epithelial cells. Even at this resolution, obtained with digital confocal imaging with a resolution of about 200 nm, it is not possible to discern with certainty whether claudin 7 is inserted into the convoluted basolateral membranes of these cell types. If so, it is possible that the cytoplasmic spots represent vesicles en route to and from to the basolateral membranes, where claudin 7 might interact with components of the extracellular matrix. As a precedent, claudin 11, an oligodendrocyte protein, has been shown to interact with α1-integrin and to regulate the proliferation and migration of oligodendrocytes in culture [20] . Other possibilities are that vesicular claudins could regulate tight-junction permeability by sequestering tight-junction regulatory molecules away from tight junctions, or they could be involved in the stabilization of specialized vesicle compartments within the cytoplasm. Matsuda and colleagues, using timelapse photography, have shown that claudin-containing cytoplasmic vesicles can originate from the tight junctions as the epithelial layer remodels [13] . However, because claudin 7 is never observed in association with tight junctions in mammary epithelial cells, it seems unlikely that these vesicles have an origin in the junctional complex. Our mammary epithelial cell model, EPH4 cells, does possess a complement of cytoplasmic vesicles that could allow livecell imaging studies to determine the origin and disposition of claudin 7-containing vesicles. It is likely that the function of the vesicles can be better assessed after analysis of the composition of the claudin 7-containing cytoplasmic vesicles.
Claudin 7 expression was inversely correlated with histological grade in a large series of breast tumors [5] . These same authors found, similarly to our observations with EPH4 cells, that claudin 7 colocalized with ZO1 in MCF7 breast cancer cells and could also be observed in cytoplasmic spots. It was present in luminal cells of the human breast, where the diaminobenzidine staining seemed to be localized to basolateral membranes, although it is difficult to draw a firm conclusion in the absence of an apical marker like ZO1. An image of ductal carcinoma in situ in that paper shows a distribution of stain remarkably similar to that of the TM10 tumor shown in Fig. 4b . This tumor line has been shown to have a ductal morphology [10] .
Thus, we conclude that low-grade breast carcinomas show a cellular distribution of stain similar to that observed in the murine tumors. Interestingly, the murine tumors showed claudin 7 expression at the mRNA level equal to or higher than that of the lactating mammary gland, where the largest proportion of the cells are the luminal epithelial cells that give rise to mammary tumors. TM4, the most tumorigenic of these lines, had the highest claudin 7 expression, although the level was quite variable and not significantly different from the other lines examined. Interestingly, TM4 and the MMTV-neu tumor had ratios of claudin 7 to cytokeratin less than one-eighth of that in the slower-growing TM10 line. All of the tumors had claudin 7 to cytokeratin ratios significantly higher than those in the pregnant or lactating mammary gland. These observations suggest that loss of the cytoplasmic architectural stability conferred by keratin might be an early event in tumorigenesis. Together with the data from the Sukumar laboratory [5] , we might speculate that loss of claudin 7, as occurs in high-grade tumors, alters cell-matrix interactions, allowing a greater degree of cell mobility and contributing to metastasis.
Conclusion
Claudin 7 is a constitutive component of mammary epithelium at all stages of development, maintaining a level of gene expression that is approximately proportional to the amount of epithelial tissue in the gland. The protein is not associated with tight junctions but is found in particulate structures in the cytoplasm, generally denser at basolateral borders of the cells. Its distribution is similar in mammary tumors, at least in more well-differentiated ones. Claudin 7 function in the mammary epithelium is currently unknown but might be related to vesicle trafficking or cell-matrix interactions.
